Dr. Zhigao Wang's grant titled “Regulation of cell death and disease by a novel membrane protein MADMAN” was awarded by the National Institute of General Medical Sciences (NIGMS) on 9/1/2022. Dr Wang was also selected as a Review Editor on the Editorial Board of Regulated Cell Death for journal Frontiers in Cell Death.
Dr. Christine Klemens was awarded a highly competitive K99 grant from the NIH NHLBI section to study the role of an understudied chloride transporter, ClC-6, in renal and vascular function during hypertension. These studies will provide further mechanistic insight to the role of this protein in blood pressure regulation in normotensive and pathological conditions. Dr. Klemens received her PhD from the University of Pittsburgh and was previously a postdoctoral fellow at the Medical College of Wisconsin. She is currently a Research Associate under the mentorship of Dr. Alexander Staruschenko, the current director of the Hypertension and Kidney Research Center, part of the USF School of Medicine Heart Institute.
Dr. DaZhi Wang was invited to give a seminar at the Stanford Cardiovascular Institute, Stanford University, on Jan 18, 2022. The title of his presentation was "Molecular Regulation of Cardiac Function, Regeneration and Disease." This archived talk is available for viewing here: https://med.stanford.edu/cvi/events/frontiers-in-cv-science/seminar-videos-2022.html.
Professor, USF Health Heart Institute
Vice Dean for Research, Morsani College of Medicine
Associate Vice President for Research, USF Health
Professor of Internal Medicine
Associate Professor, USF Health Heart Institute
Hypertension and kidney disease have been repeatedly associated with genomic variants and alterations of lysine metabolism. Here, we combined stable isotope labeling with untargeted metabolomics to investigate lysine’s metabolic fate in vivo. Dietary 13C6 labeled lysine was tracked to lysine metabolites across various organs.
To read more about Accelerated Lysine Metabolism, click here.